Page last updated: 2024-12-11

furapyrimidone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Cross-References

ID SourceID
PubMed CID9576647
MeSH IDM0101596

Synonyms (8)

Synonym
2(1h)-pyrimidinone, tetrahydro-1-((5-nitrofurfurylidene)amino)-
tetrahydro-1-(5-nitrofurfurylideneamino)-2-pyrimidone
ccris 5503
1-((5-nitrofuranyl-2)methyleneamino)tetrahydropyrimidone-2-one
brn 0547500
furapyrimidone
75888-03-8
DTXSID10226810

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" perstans using different dosage schedules."( Clinical trial on furapyrimidone in filariasis.
Chen, MG; Fu, S; Hua, XJ; Ren, YF; Shi, ZJ; Wang, MJ; Yuan, YZ, 1984
)
0.6
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (16)

TimeframeStudies, This Drug (%)All Drugs %
pre-199014 (87.50)18.7374
1990's2 (12.50)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (6.25%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other15 (93.75%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]